-
Some Pancreatic Cancers Are Hereditary
A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.
by Cheryl Platzman Weinstock
-
July 13: The Week in Cancer News
An opinion piece discusses how the stigma surrounding opioids affects cancer patients, and a study provides data on treating melanoma patients with brain metastases.
by Kate Yandell
-
What Is ‘Chemo Brain’?
The National Cancer Institute's Todd Horowitz discusses cancer-related cognitive impairment.
by Anna Azvolinsky
-
Predicting Acute Myeloid Leukemia
Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed.
by Anna Azvolinsky
-
July 6: The Week in Cancer News
Studies explore what type of cervical cancer screening is most effective and whether patients with autoimmune diseases can take immunotherapy.
by Kate Yandell
-
June 29: The Week in Cancer News
Studies explore occupational hazards that could increase cancer risk, and the U.S. Food and Drug Administration approves a new combination therapy for melanoma.
by Kate Yandell
-
Exploring When Breath Becomes Air
Join our Facebook group to talk about themes in the poignant memoir by Paul Kalanithi.
by Marci A. Landsmann
-
Suicide Risk in Cancer Survivors
Study looks at gender difference in suicide rates among those who have been diagnosed with cancer.
by Cici Zhang
-
June 22: The Week in Cancer News
Experts debate direct-to-consumer genetic testing and studies shed light on breast reconstruction complications.
by Kate Yandell
-
Canine Comfort
Studies investigate whether visits from therapy dogs can increase the well-being of cancer patients and caregivers.
by Jen Tota McGivney
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles